Australia markets closed

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0381+0.0005 (+1.33%)
At close: 01:08PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPSN/A-0.11N/AN/A
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts0011
Avg. EstimateN/AN/A21.66M44.54M
Low estimateN/AN/A21.66M44.54M
High estimateN/AN/A21.66M44.54M
Year ago salesN/AN/AN/A21.66M
Sales growth (year/est)N/AN/AN/A105.60%
Earnings historyInvalid Date30/03/202129/06/202129/09/2021
Est. EPSN/A-0.08-0.08-0.11
Actual EPSN/A-0.11-0.09-0.08
DifferenceN/A-0.03-0.010.03
Surprise %N/A-37.50%-12.50%27.30%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate0000
7 days ago00-0.010.57
30 days ago00-0.010.57
60 days ago00-0.010.57
90 days ago00-0.010.57
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNAVBIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A